Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidové zobrazovanie - diagnostické rádiofarmaká - tento liek je určený len na diagnostické účely. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

paul hartmann ag paul hartmann str. 12 895 22 heidenheim nemecko -

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - elotuzumab - viacnásobný myelóm - antineoplastické činidlá - empliciti je indikovaný v kombinácii s lenalidomide a dexamethasone pre liečbu myelómom je mladších dospelých pacientov, ktorí dostali aspoň jeden pred liečby (pozri časť 4. 2 a 5.

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bb pharma a.s., Česká republika - neostigmín - 67 - parasympathomimetica

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Unjoni Ewropea - Slovakk - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovakkja - Slovakk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teva b.v., holandsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)